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One cause of the excessive deposition of collagen in 
systemic sclerosis is thought to be abnormal function-
ing of fibroblasts . The purpose of this study is to deter-
JDine whether there is decreased expression of colla-
genase in systemic sclerosis fibroblasts . In this study, 
we analyzed collagen and collagenase expression in 
dermal fibroblasts derived from eight patients with 
systemic sclerosis and compared the findings with 
those from nine sex- and age-matched healthy subjects. 
Increased collagen synthesis accompanying enhanced 
mRNA levels was observed in two of eight strains, 
whereas all eight strains showed remarkable decreases 
in collagenase activity and production. There were no 
Systemic sclerosis (SSc) is characterized by excessive accu-mulation of collagen in the skin and in certain internal organs [1- 3]. As a result, many investigations of the colla-gen metabolism of SSc, and particularly of collagen syn-thesis, have been performed [4 - 7]. However, it has not 
yet been determined whether collagen production is enhanced and/ 
or whether collagen degradation is decreased in SSc. In most of the 
above studies, in which cultured skin fibroblasts established from 
patients were used, increased collagen synthesis was found [4-6]. 
To date, it has been considered that the accumulation of collagen in 
SSc is due to increased collagen synthesis. However, increases were 
demonstrated in only about half of the SSc fibroblast cultures in 
these studies, and in one study [7] increased collagen production 
could not be demonstrated in any SSc fibroblast cultures. The ex-
pression of collagenase, a met~lloprotease with the unique abi lity to 
initiate collagen degradatIOn 111 SSc fibroblast cultures, has not been 
sufficiently studied and is poorly understood . Here, we report our 
findings regarding both collagen and collagenase expression in der-
mal fibrob lasts from eight SSc patients and from nine sex- and 
age-matched hea lthy subjects. Our data showed that collagen pro-
duction increased in two of eight SSc fibroblast cultures, whereas 
collagenase production and activity clearly decreased in all of the 
SSc fibroblast cultures. This suggests that decreased collagenase ex-
pression is a characteristic of SSc fibroblasts and the excessive accu-
mulation of collagen in SSc is due to both increased collagen pro-
duction and decreased collagenase expression in SSc fibroblasts. 
MATERIALS AND METHODS 
Fibroblast Cultures Skin fibroblasts were obtained from eight fema le 
patients with SSc, and nine sex- and age-matched normal subjects. T he 
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differences in the levels of collagenase mRNA between 
the systemic sclerosis strains and the normal strains. 
Results suggest that decreased collagenase expression 
is a characteristic of systemic sclerosis fibroblasts, and 
both increased collagen expression and decreased col-
lagenase expression in systemic sclerosis fibroblasts 
may result in the excessive accumulation of collagen in 
patients with systemic sclerosis. It is also suggested that 
decreased collagenase expression is altered at transla-
tional and/ or post-translational levels. Key words: colla-
genase production I collagenase activity I scleroderma. ] Invest 
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profiles of the patients and the fibroblast strains used in this study are listed in 
Table I. Primary cultures of the dermal fibrobl asts were established by the 
outgrowth method as described previously [9]. The cultures were main-
tained with Du lbecco's modified Eagle's medium (DMEM) with 10% fetal 
bovine serum (FBS) in a CO2 incubator at 37 °C. Cells were utilized for each 
comparative study at a two to three population doubling level (POL). 
Assay of Collagenase Activity Fibroblast strains obtained from eight 
SSc patients (SI - S8) and nine normal subjects (N1-N9) by the outgrowth 
technique were seeded onto six-well multi plate dishes and cultured with 
DMEM containing 10% FBS. After the ce lls grew to confluence, the me-
dium was removed, the cell layer was rinsed three times with phosphate-
buffered sa line (PBS), and 2 ml of serum-free DMEM was added, and the 
culture was continued for 48 h in a CO2 incubator at 37 °C. After the 
medium was removed, 1 M Tris-HCI (pH 7.5) and 1 M CaCI2 were added to 
give final concentrations of 0.05 M and 0.01 M, respectively, and stored at 
-80 °C for the assay. Collagenase activity was assayed by the solution 
method [10,11 J using fluorescein isothiocya nate (FITC) - labeled type I col-
lagen as a substrate as described previously [12]. One unit of collagenase 
activity is defined as the amount of enzyme degrading 1 /lg of collagen per 
minute under the conditions employed. The enzyme activity was expressed 
as units per 106 ce lls for each dish. 
Immunologic Determination of Collagenase Normal and sclero-
derma fibroblasts were seeded onto six-wellmultiplate dishes and cultured 
with DMEM containing 10% FBS. After the cells grew to confluence, the 
medium was removed, the ce ll layer was rinsed three times with PBS, and 
2 ml of serum-free DMEM was added. The culture was incubated for 48 h in 
a CO2 incubator at 37°C. The medium was then conccntrated by trichloro-
acetic acid precipitation and separated using sodium dodecylsulfate -
polyacrylamide gel electrophoresis (SDS-PAGE) (10% gel) under reducing 
conditions. Western blotting was performed according to the method of 
Towbin et 01 [13J . The blotted nitrocellulosc membrane was blocked over-
night at 4 °C with 10% normal goa t serum in Tris-bulfered saline (TBS). pH 
8.0, and incubated for 1 h at room temperature with anti-human collagenase 
antibody [14]. After extensive washing, mouse IgG fixed on the membrane 
were detected by avid in-biotin-peroxidase complex (ABC) method (Vector 
Laboratories Inc. , Burlingame, CAl. Immunoreactive collagenase was deter-
mined by scanning with a densitometer (DU-8 Spectrophotometer, Beck-
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Table I. Skin Fibroblast Strains and Descriptions of the 
Patients with Systemic Sclerosis 
Name of Age Biopsy Antinuclear 
the Strain (years) Duration Type' Site Antibody 
Sl 61 8 months III Abdomen (-) 
S2 47 1 year II Forearm Scl-70(+) 
S3 48 9 months III Abdomen (-) 
S4 47 1 year I Forearm Scl-70(+) 
S5 43 2 years II Forearm Scl-70(+) 
S6 42 13 years II Forearm Scl-70(+) 
S7 54 12 years II Forearm Scl-70(+) 
S8 49 20 years II Forearm Scl-70(+) 
• Barnett's classification [8). Type I: sclerosis limited to the fingers (Raynaud's phe-
nomenon and sclerodactyly) . Type II: sclerosis is not confined to the digits but extends 
to the hands and forearms (acrosclerosis). Type III : sclerosis is diffuse, affecting the 
entire skin (systemic scleroderma with diffuse skin change). 
man, Fullerton. CAl. All values of immunoreactive collagenase are normal-
ized to the same number of cells. 
Measurement of Collagen and Non-Collagenous Protein Syn-
thesis Both SSe and normal fibrobl asts in early passages were seeded onto 
12-well multiplate dishes and cultured with DMEM containing 10% FBS 
until they grew to confluence. Then the medium was removed and the cell 
layer was rinsed twice with PBS. The culture was re-fed with serum-free 
DMEM containing 0.1 mM ascorbic acid, 0.1 mM fJ-aminopropionitri le, 
and 10 JlCi/ ml L-(2.3-3H] proline (NEN Chemicals. Boston. MA) and the 
incubation was continued for 3 h. Incorporation into collagen and non-col-
lagenous protein was determined using purified bacterial collagenase as de-
scribed previously (9]. The relative rate of collagen synthesis to total protein 
synthesis was calculated by the formula: collagenous dpm X 1001 
(collagenous dpm + (non-collagenous protein dpm X 5.4)] = % as de-
scribed previously [15]. 
RNA Extraction and Analysis of mRNA Levels Fibroblasts at two or 
three PDL from patients with SSc (Sl -S8) and from normal individuals 
(Nl : N9) were inocul ated onto 150 X 25 mm plastic dishes. When the 
cells achieved confluence. the medium was removed and the cells were 
washed twice with cold PBS. Then 5 M guanidine thiocyanate solution 
containing 0.75% mercaptoethanol was used for RNA extraction. The total 
RNA obtained was layered over 5.7 M cesium chloride and purified by 
ultracentrifugation. The levels of mRNA were measured as previously de-
scribed [16). Plasmids HF-667 with a 1.5-Kb insert specific for the lX, (I) 
collagen chain (17]. plasmids K4 with a 0.7-Kb insert specific for collagenase 
[18], and plasmids pHFA-1 with a 0.5-Kb insert for fJ-actin [19) were used as 
DNA probes for type I collagen. collagenase. and fJ-actin mRNA. respec-
tively. 
RESULTS 
The collagenase activity in fibrobl asts was measured as the degrada-
tion rate of FITC-labeled type I collagen by culture supernatants 
(Fig 1). In the healthy control. collagenolytic activity of culture 
supernatants was 0.86 ± 0 .3 U /106 cells. On the other hand. much 
less activity was found in SSc fibroblasts. The average value of 
collagenolytic activity in SSc fibroblast culture supernatants w as 
0 .05 ± 0.05 U /106 cells; it was significantly decreased to 6% of the 
control value. 
Collagenase production was examined by the immunoblot analy-
sis. Mr = 57.000 and Mr = 52.000 species as collagenase were 
clearly detected in all samples (Fig 2). Quantified immunoreactive 
coll agenase in normal and SSc fibroblast cultures are displayed in 
Table II and that in SSc fibroblast cultures were shown to be de-
creased to 27% (upper band. 22.0%; lower band. 32.0%). 
The collagenous and non-collagenous protein synthesis of SSc 
and normal fibroblast strains w as measured and the relative rate of 
coll agen sy nthesis to total protein synthesis was calculated (Table 
III) . Both collagenous and non-collagenous protein synthesis in SSc 
fibrobl asts were approximately 1.5 times higher than those in nor-
mal fibroblasts. The relative rates of collagen synthesis were in-
creased in two SSc fibroblast strains (S 1. S2) and remained at normal 
levels in most of the SSc strains. To determine whether the de-
creased levels of collagenase production were due to the reduced 
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Figure 1. Collagenase activity in dermal fibroblasts derived from 
patients with SSe and normal individuals. Collagenase activity in the 
culture medium was measured with FITC-Iabeled bovine type I collagen 
substrate. The values are expressed as the mean ± standard deviation (SD) of 
the unit (U) per 106 cells. 
collagenase mRNA levels. we measured the mRNA levels of colla-
genase. Interestingly . the levels of collagenase mRNA in the SSc 
fibroblasts as well as jJ-actin mRNA were normal (Fig 3A,C) . The 
levels of a l (I) collagen mRNA w ere increased in only two SSe 
strains which showed increased levels of collagen synthesis. and 
normal levels were observed in the other six strains (Fig 3B) . No 
qualitative differences between the control and SSc fibroblasts in 
these mRNA transcripts were detected by Northern blot analysis 
(Fig 4). 
DISCUSSION 
Increased collagen synthesis in cultured fibroblasts from patients 
with SSc has been demonstrated in several studies. However, LeRoy 
et al [4] reported increased collagen synthesis in nine of 12 SSc 
fibroblast strains. Uitto et al [5] in five of eight SSc fibroblast strains. 
and Krieg et al [6] in five of 10 fibroblast strains. And Perlish et al [7J 
were unable to demonstrate increased collagen production in any of 
their nine SSc fibroblast cultures. In this study. we found increased 
collagen synthesis in only two of eight SSc fibroblast strains. It is not 
surprising that collagen production was not elevated in fibroblast 
strains S5-S8 (disease duration: 2 years, 13 years. 12 years. and 20 
years). because fibrobl asts from late, atrophic scleroderma skin have 
never been shown to produce increased levels of collagen. Thus. 
two of the four cultures from recent onset patients showed increased 
collagen synthesis. and this result is nearly in agreement with 
previous reports [4 - 6]. Alternatively . decreased expression of colla-
genase, a metalloprotease with the unique ability to initiate collagen 
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degradation in SSc fibroblasts, may be one possible condition caus-
ing excessive accumulation of collagen in patients with SSc. In this 
study, the coll agenase activity in SSc fibroblast cultures was found to 
be reduced to 6%, w hereas the collagenase production levels were 
reduced to 27%. Decreased levels were demonstrated in collagenase 
production but not in collagen and non-collagenous protein pro-
duction in SSc fibroblasts. These data imply that decreased colla-
genase production is not due to decreased level of total protein 
production. 
Observations of decreased protein production levels and unal-
tered mRNA levels of collagenase in SSc fibroblasts suggest that the 
expression of collagenase was altered at translational and/or post-
translational levels in the SSc fibroblasts. Because collagen synthesis 
in scleroderma seems to be controlled at the transcriptional level, 
the suggestion that decreased collagenase in SSe fibroblasts is con-
trolled post-transcriptionally required an independent control 
mechanism differing from the established transcriptional level reg-
ulation already demonstrated for collagens I [20,21], III [20,22] , VI 
[23], and fibronectin [24,25]. Recently, it has been suggested that 
transforming growth factor-fJ (TGF-fJ) may play a role in mediating 
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Figure 2. Immunologic determination of collagenase by immuno-
blot analysis. Two experiments were performed (A, experiment 1; B, ex-
periment 2). The two arrows indicate the positions of collagenase: IIpper 
arrow, 58 Kd ; JOllier arrOIll, 55 Kd. The headings above lanes refer to cell 
strains (see Assay oj Col/agel/ase Activity above). 
Table II. Immunoreactive Collagenase Synthesized by 
Systemic Sclerosis Fibroblasts in Culture 
Cell Strain Relative Density" 
Experiment 1 
S5 U' 47.9' L 68.6 
S2 U 43.8 L 36.6 
S3 U 25.0 L 44.2 
S8 U 11.0 L 28.4 
S7 U 9.8 L 21.0 
S6 U 6.3 L 11.6 
U 24.0 ± 18.2J 
SSe (n = 6) L 35.1 ± 20.0 
Mean 29.5 
Experiment 2 
SI U 17.2 
L 29.9 
S4 U 14.8 
L 16.0 
U 16.0 
SSc (n = 2) L 23.0 
Mean 19.5 
Experiments 1 and 2 
U 22.0 ± 15.8 
SSe (n = 8) L 32.0 ± 18.2 
Mean 27.0 
., InUllunorcactivc coll agenase was derermined by sca nning w ith a densitometer. 
, U, upper band, L, lower band. 
, Values were expressed as the percent compared to the average of normal controls. 
J Val ues given arc rhe mean ± SO. 
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Table III. Collagen and Non-Collagenous Protein 
Synthesis by Dermal Fibroblasts from Patients with 
Systemic Sclerosis 
Collagenous Non-collagenous Relative 
Cell Protein Protein Rate 
Strain (dpm X 10-2/10' ce ll s) (dpm X 10- 2/10' cel ls) (%)b 
SSc 
Sl 20 31 10.7 
S2 18 30 10.0 
S3 22 46 8.1 
S4 5 10 8.5 
S5 16 37 7.4 
S6 18 36 8.5 
S7 5 11 7.8 
S8 4 10 6.9 
14 ± 8' 26 ± 14' 8.5 ± 1.3' 
Normal 
Nl 6 14 7.4 
N2 9 17 8.9 
N3 15 32 8.0 
N4 14 24 9.7 
N5 6 15 6.9 
N6 5 16 5.5 
N7 8 16 8.5 
N8 6 15 6.9 
N9 8 20 6.9 
9 ± 4' 19 ± 6' 7.6 ± 1.3' 
, Values given are the mean ± so. 
I The relative rate of collagen synthesis was calculated by the formula: % = 
(collagenous protein dpm X IOO)/[collagenous protein dpm + (non-collagenous pro-
tein dpm X 5.4)]. 
the collagen gene disregulation of SSc dermis and other involved 
organs [26,27] . Furthermore, it has been reported that TGF-p re-
duces the expression of collagenase in cultured fibroblasts at mRNA 
levels [28]. In this study, we observed decreased collagenase produc-
tion and unaltered collagenase mRNA levels. Therefore, the step of 
regulation of collagenase in SSc fibroblasts under basal conditions 
differs from that found in fibroblasts cultured with TGF-p. 
We not only obtained control fibroblasts from age-matched 
healthy individuals but also used PDL-matched control fibrobl asts, 
because collagenase production in human skin fibroblasts is modu-
lated by in vitro aging [29] . An early study [5] demonstrated no 
marked differences in the expression of collagenase in eight fibro-
blast strains from patients with SSc. There may be several possible 
explanations for the discrepancy between our study and that report 
[5]. First, the ages of the control healthy individuals used in that 
report were not very well matched with those of the SSc patients. A 
second explanation for the different results may be found in the 
varying conditions employed for primary cultures and subcultiva-
tions of fibroblasts . Brady [30] reported that decreased collagenase 
activity was observed in the clinically affected skin tissue of SSc 
patients, and Hermann et al [24] reported the presence of normal 
levels of collagenase mRNA in SSc skin . These two reports are 
nearly in agreement with our findings . 
The collagenase activity in SSc fibroblast cultures was found to be 
reduced to 6%, whereas the collagenase production levels were 
reduced to 27%. These findings suggest that collagenase activity in 
SSc fibroblast cultures is reduced by some mechanism other than a 
simple decrease in production. One possible mechanism is enhanced 
levels of an inhibitor of collagenase, such as a2 macroglobulin [31 -
33] or TIMP (tissue inhibitor of metalloproteinases) [34] . Recently, 
Mayes and Kirki' have reported that one fibroblast strain derived 
from the affected skin of a scleroderma patient exhibited little or no 
collagenase activity and increased TIMP production. They pro-
t Mayes MD, Kirk TZ: Increased TIMP (tissue inhibitor of metallopro-
teinase) with decreased collagenase activity in scleroderma fibroblasts 
(abstr). Arthritis Rheum 34 (suppl 9): Ill, 1991. 
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Figure 3. Blot quantification of collagenase, a,(I) collagen, and p. 
actin mRNAs of SSc fibroblasts. Serial dilutions of total RNA (4, 2, 1, 
and 0.5 jig) derived from patients with SSc and normal individuals were 
dotted onto a nitrocellulose filter, baked, and hybridized with eDNA probes 
of collagenase (A), a.(I) collagen (B), and p-aetin (C). 
posed that the decreased collagenase activity might be due to exces 
pro~uction of TIMP. The determination of TIMP production of 
additional scleroderma stral11S should help in further discussion of 
this discrepancy. 
Most of the SSc fibroblast strains used in this study were obtained 
from affected skin, and the levels of collagenase expression of these 
strains were shown to have decreased. However, the levels of colla· 
genase expression also decreased in one strain (S4) obtained from 
unaffected skin. It might be possible that the decreases do not de-
pend on skin changes at the biopsy sites from which fibroblast 
strains. ,:"ere derived .. The determination of collagenase expression 
of additional SSc strams from unaffected skin should help in further 
studies . 
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Pi ure 4. Northern blot detection of collagenase, 0', (1) collagen, and fJ-actin mRNAs of SSc fibroblasts. Total RNA obtained from dermal fib~oblasts derived from patients with SSe (Sl - S8) and normal1l1dtv tduals (Nl) were electrophoresed and transferred to nttrocc llulose, and mRNAs were 
hybridized to labeled eDNA. The positions of 28S and 18S RNA are 1I1dtcated by bars. 
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